EP3313829
Samsetningar af lípíðum og lípíð-nanóögnum til dreifingar á kjarnsýrum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.6.2016EP published:
10.4.2024EP application number:
16738338.9
EP translation filed:
8.7.2024Grant published:
15.9.2024EPO information:
European Patent Register
Max expiry date:
28.6.2036Expiry date:
28.6.2026Next due date:
30.6.2026
Title in English:
LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDSLanguage of the patent:
English
Timeline
Today
29.6.2016EP application
10.4.2024EP Publication
8.7.2024Translation submitted
15.9.2024Registration published
28.6.2026Expires
Owner
Name:
Acuitas Therapeutics Inc.Address:
6190 Agronomy Road Suite 402 University of British Columbia - KETR, Vancouver, British Columbia V6T 1W5, CA
Inventor
Name:
DU, XinyaoAddress:
Richmond, British Columbia V7A 2M1, CA
Name:
ANSELL, Steven, M.Address:
Vancouver, British Columbia V6J 1W5, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562186210 PDate:
29.6.2015Country:
US
Classification
Categories:
C07D 295/13, C07C 211/22, C07C 233/36, C07C 233/38, C07C 235/74, A61K 47/18
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 24.6.2024
Expires: 28.6.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 18.6.2025
Expires: 28.6.2026
Payer: Árnason Faktor ehf.